CLINICAL_TRIALS
research
· 2025-07-08
Clinical Trial Update: Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia [Phase 2]
Summary
Phase 2 study evaluating progesterone to improve management of preterm severe or superimposed preeclampsia is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Mississippi Medical Center | Conditions: Pregnancy, Preeclampsia (PE) | Phase 2 | Status: RECRUITING